K. Stengaard‐Pedersen

4.3k total citations
65 papers, 2.4k citations indexed

About

K. Stengaard‐Pedersen is a scholar working on Rheumatology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, K. Stengaard‐Pedersen has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 17 papers in Molecular Biology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in K. Stengaard‐Pedersen's work include Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (15 papers) and Neuropeptides and Animal Physiology (13 papers). K. Stengaard‐Pedersen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (15 papers) and Neuropeptides and Animal Physiology (13 papers). K. Stengaard‐Pedersen collaborates with scholars based in Denmark, United States and Belgium. K. Stengaard‐Pedersen's co-authors include Ulrich Fredberg, Lars Larsson, K. Fredens, Anne Grethe Jurik, Kim Hørslev‐Petersen, Berit Schiøttz‐Christensen, G. Hansen, Niels Egund, Lars Bolvig and Anders Jørgen Svendsen and has published in prestigious journals such as Brain Research, Food Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

K. Stengaard‐Pedersen

65 papers receiving 2.3k citations

Peers

K. Stengaard‐Pedersen
Aad Verrips Netherlands
Julia J. Inglis United Kingdom
Jun Ma China
Matthew J. Schwei United States
Aad Verrips Netherlands
K. Stengaard‐Pedersen
Citations per year, relative to K. Stengaard‐Pedersen K. Stengaard‐Pedersen (= 1×) peers Aad Verrips

Countries citing papers authored by K. Stengaard‐Pedersen

Since Specialization
Citations

This map shows the geographic impact of K. Stengaard‐Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Stengaard‐Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Stengaard‐Pedersen more than expected).

Fields of papers citing papers by K. Stengaard‐Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Stengaard‐Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Stengaard‐Pedersen. The network helps show where K. Stengaard‐Pedersen may publish in the future.

Co-authorship network of co-authors of K. Stengaard‐Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Stengaard‐Pedersen. A scholar is included among the top collaborators of K. Stengaard‐Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Stengaard‐Pedersen. K. Stengaard‐Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Troldborg, Anne, et al.. (2019). Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis: improvement of disease identification. Clinical & Experimental Immunology. 199(1). 79–87. 13 indexed citations
2.
Stengaard‐Pedersen, K., Magnus Christian Lydolph, Finn Somnier, & Peter Junker. (2016). [Myopathy in a patient during simvastatin and fluconazole treatment].. PubMed. 178(39). 1 indexed citations
3.
Ellingsen, Torkell, I. Hansen, Ulrik Tarp, et al.. (2013). Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression. Scandinavian Journal of Rheumatology. 43(2). 91–100. 19 indexed citations
4.
Stengaard‐Pedersen, K., et al.. (2011). Prevalence of Rheumatoid Arthritis in the Southern Part of Denmark. The Open Rheumatology Journal. 5(1). 91–97. 16 indexed citations
5.
Christensen, Anne Friesgaard, Hanne Lindegaard, Kim Hørslev‐Petersen, et al.. (2011). Cartilage Oligomeric Matrix Protein Associates Differentially with Erosions and Synovitis and Has a Different Temporal Course in Cyclic Citrullinated Peptide Antibody (Anti-CCP)-positive versus Anti-CCP-negative Early Rheumatoid Arthritis. The Journal of Rheumatology. 38(8). 1563–1568. 11 indexed citations
6.
Hetland, Merete Lund, K. Stengaard‐Pedersen, Peter Junker, et al.. (2010). Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Annals of the Rheumatic Diseases. 69(10). 1789–1795. 148 indexed citations
7.
Thurah, Annette de, Mette Nørgaard, Martin Berg Johansen, & K. Stengaard‐Pedersen. (2009). Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital. Scandinavian Journal of Rheumatology. 39(1). 19–25. 9 indexed citations
8.
Stengaard‐Pedersen, K., Niels Kristian Kjær, Anders Jørgen Svendsen, & Kim Hørslev‐Petersen. (2008). Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatology International. 29(4). 411–415. 53 indexed citations
9.
Fredberg, Ulrich & K. Stengaard‐Pedersen. (2008). Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scandinavian Journal of Medicine and Science in Sports. 18(1). 3–15. 218 indexed citations
10.
Hetland, Merete Lund, M. Østergaard, A Vestergaard, et al.. (2007). Is it possible to stop radiographic progression with conventional treatment in early rheumatoid arthritis?: 2 years results from the CIMESTRA study. Annals of the Rheumatic Diseases. 1 indexed citations
11.
12.
Stengaard‐Pedersen, K., Anders Jørgen Svendsen, & Kim Hørslev‐Petersen. (2007). Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001. The Open Rheumatology Journal. 1(1). 18–23. 47 indexed citations
14.
Svendsen, Kristina B., Torkell Ellingsen, Jesper Nørgaard Bech, et al.. (2005). Urinary excretion of α‐GST and albumin in rheumatoid arthritis patients treated with methotrexate or other DMARDs alone or in combination with NSAIDs. Scandinavian Journal of Rheumatology. 34(1). 34–39. 16 indexed citations
15.
Jurik, Anne Grethe, et al.. (2004). MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1‐year follow‐up study. Scandinavian Journal of Rheumatology. 33(5). 332–338. 61 indexed citations
17.
Puhakka, Katriina Bøcker, Anne Grethe Jurik, Niels Egund, et al.. (2003). Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. University of Southern Denmark Research Portal (University of Southern Denmark). 142 indexed citations
18.
Storgaard, Merete, et al.. (1996). Effects of Methotrexate, Sulphasalazine and Aurothiomalate on Polymorphonuclear Leucocytes in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 25(3). 168–173. 8 indexed citations
19.
Hansen, G., et al.. (1996). Nutritional Status of Danish Rheumatoid Arthritis Patients and Effects of a Diet Adjusted in Energy Intake, Fish-meal, and Antioxidants. Scandinavian Journal of Rheumatology. 25(5). 325–333. 37 indexed citations
20.
Stengaard‐Pedersen, K., et al.. (1996). Synovial cysts of the hips in seronegative arthritis. Skeletal Radiology. 25(4). 396–399. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026